Tempus Multimodal Immune Profile Score Test
Tempus AI has launched a research-use-only version of its multimodal immune profile score (IPS) algorithmic test. IPS is a pan-cancer, laboratory-developed test that assesses a combination of immunotherapy-related biomarkers from prior DNA and RNA test results to calculate a score from zero to 100 and a classification of either IPS-Low or IPS-High. IPS results can support patient stratification across pan-cancer cohorts to help inform response to immunotherapy. The IPS test is intended to be an add-on option for clinicians ordering Tempus' xT and xR at the end of the year.
MSAID Proteomic Data Analysis Platform
MSAID has launched new software for proteomic data analysis. It is a scalable, automatable, cloud-based software-as-a-service platform for various proteomic data workflows that is powered by the firm's Chimerys 4 proteomics search software. It also features API integration for automation and connecting with existing cloud-based platforms.
For more recently launched products and services, please visit the New Products page on our website.